Fresh boost for interferon drugs
The battle for the lucrative market for multiple sclerosis drugs will hot up with publication of two papers in the Lancet, the UK medical journal, demonstrating that interferon-alpha is an effective
The battle for the lucrative market for multiple sclerosis drugs will hot up with publication of two papers in the Lancet, the UK medical journal, demonstrating that interferon-alpha is an effective